Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disentangling the veil line for Brazilian biodiversity: An overview from two long-term research programs reveals huge gaps in ecological data reporting.
Guimaraes AF, de Alagao Querido LC, Rocha T, de Jesus Rodrigues D, Viana PL, de Godoy Bergallo H, Fernandes GW, Toma TSP, Streit H, Overbeck GE, de Souza AQS, Lima AP, da Rosa CA, de Viveiros Grelle CE, Lopes AM, Curcino A, de Paula AS, Andriolo A, Dos Santos Dias A, Santos AT, Bernardes AA, da Silva Oliveira AB, de Barros AAM, E Silva ACBL, da Cruz ACR, de Holanda ASS, Bueno AS, Nunes-Freitas AF, Yves A, da Silva Alencar A, Scabin AB, Manzatto AG, Lima ACS, Pontes ARM, Castro AB, Gomes AM, Banhos A, Rosado BHP, Dos Santos Batista CA, Siqueira CC, Fontana CS, da Rocha CFD, Brocardo CR, da Costa Doria CR, Castilho CV, Pessanha C, Cordeiro CAMM, Cronemberger C, Andretti CB, Cornelius C, Campos C, Borges-Matos C, Barros CF, Keller C, de Oliveira Cavalcante C, de Sales Dambros C, da Silva Machado DN, Tassinari D, Villela DM, Chiaraniv E, de Farias Geisler E, Velez-Martin E, Carvalho-Junior EAR, Drechsler-Santos ER, Lourenco EC, Franklin E, Higashikawa EM, Pezzini F, de Oliveira Roque F, Baccaro FB, Becker FG, Cabeceira FG, do Prado Florencio F, Barbosa FR, Pezzini F, Zuquim G, Ferreira GB, de Vargas GK, Mourao G, Rousseau GX, de Lima HC, Farias HLS, Kaefer IL, Ghizoni IR, da Co… See abstract for full author list ➔ Guimaraes AF, et al. Among authors: tassinari d. Sci Total Environ. 2024 Nov 10;950:174880. doi: 10.1016/j.scitotenv.2024.174880. Epub 2024 Jul 23. Sci Total Environ. 2024. PMID: 39053522 Review.
Prophylaxis and treatment of peritoneal carcinomatosis of gastric origin using hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis of randomized trials.
Stefano M, Perrina D, Vallicelli C, Ansaloni L, Fugazzola P, Coccolini F, Agnoletti V, Frassineti GL, Passardi A, Tamberi S, Framarini M, Tassinari D, Matteucci L, Sturaro C, Gallo G, Catena F. Stefano M, et al. Among authors: tassinari d. J Gastrointest Surg. 2024 Jul;28(7):1185-1193. doi: 10.1016/j.gassur.2024.04.007. Epub 2024 Apr 8. J Gastrointest Surg. 2024. PMID: 38599315 Review.
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1.
Besse B, Felip E, Garcia Campelo R, Cobo M, Mascaux C, Madroszyk A, Cappuzzo F, Hilgers W, Romano G, Denis F, Viteri S, Debieuvre D, Galetta D, Baldini E, Razaq M, Robinet G, Maio M, Delmonte A, Roch B, Masson P, Schuette W, Zer A, Remon J, Costantini D, Vasseur B, Dziadziuszko R, Giaccone G; ATALANTE-1 study group. Besse B, et al. Ann Oncol. 2023 Oct;34(10):920-933. doi: 10.1016/j.annonc.2023.07.006. Epub 2023 Sep 11. Ann Oncol. 2023. PMID: 37704166 Free article. Clinical Trial.
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
Tsuboi M, Herbst RS, John T, Kato T, Majem M, Grohé C, Wang J, Goldman JW, Lu S, Su WC, de Marinis F, Shepherd FA, Lee KH, Le NT, Dechaphunkul A, Kowalski D, Poole L, Bolanos A, Rukazenkov Y, Wu YL; ADAURA Investigators. Tsuboi M, et al. N Engl J Med. 2023 Jul 13;389(2):137-147. doi: 10.1056/NEJMoa2304594. Epub 2023 Jun 4. N Engl J Med. 2023. PMID: 37272535 Clinical Trial.
Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients.
Gurioli G, Tedaldi G, Farolfi A, Petracci E, Casanova C, Comerci G, Danesi R, Arcangeli V, Ravegnani M, Calistri D, Zampiga V, Cangini I, Fonzi E, Virga A, Tassinari D, Rosati M, Ulivi P, De Giorgi U. Gurioli G, et al. Among authors: tassinari d. Int J Mol Sci. 2022 Dec 13;23(24):15789. doi: 10.3390/ijms232415789. Int J Mol Sci. 2022. PMID: 36555431 Free PMC article.
Adjuvant chemotherapy after neoadjuvant chemo-radiotherapy and surgery in locally advanced rectal cancer. A systematic review of literature with a meta-analysis of randomized clinical trials.
Tamburini E, Tassinari D, Ramundo M, De Stefano A, Viola MG, Romano C, Elia MT, Zanaletti N, Rudnas B, Casadei-Gardini A, Delrio P, Toma I, Granata V, Petrucelli L, Avallone A. Tamburini E, et al. Among authors: tassinari d. Crit Rev Oncol Hematol. 2022 Apr;172:103627. doi: 10.1016/j.critrevonc.2022.103627. Epub 2022 Feb 22. Crit Rev Oncol Hematol. 2022. PMID: 35202817 Review.
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG.
Bersanelli M, Giannarelli D, De Giorgi U, Pignata S, Di Maio M, Verzoni E, Clemente A, Guadalupi V, Signorelli D, Tiseo M, Giusti R, Filetti M, Di Napoli M, Calvetti L, Cappetta A, Ermacora P, Zara D, Barbieri F, Baldessari C, Scotti V, Mazzoni F, Veccia A, Guglielmini PF, Maruzzo M, Rossi E, Grossi F, Casadei C, Cortellini A, Verderame F, Montesarchio V, Rizzo M, Mencoboni M, Zustovich F, Fratino L, Cinieri S, Negrini G, Banzi M, Sorarù M, Zucali PA, Lacidogna G, Russo A, Battelli N, Fornarini G, Mucciarini C, Bracarda S, Bonetti A, Pezzuolo D, Longo L, Sartori D, Iannopollo M, Cavanna L, Meriggi F, Tassinari D, Corbo C, Gernone A, Prati V, Carnio S, Giordano P, Dicorato AM, Verusio C, Atzori F, Carrozza F, Gori S, Castro A, Pilotto S, Vaccaro V, Garzoli E, Di Costanzo F, Maiello E, Labianca R, Pinto C, Tognetto M, Buti S. Bersanelli M, et al. Among authors: tassinari d. Ther Adv Med Oncol. 2020 Nov 2;12:1758835920968463. doi: 10.1177/1758835920968463. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 33224275 Free PMC article.
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.
Wu YL, Tsuboi M, He J, John T, Grohe C, Majem M, Goldman JW, Laktionov K, Kim SW, Kato T, Vu HV, Lu S, Lee KY, Akewanlop C, Yu CJ, de Marinis F, Bonanno L, Domine M, Shepherd FA, Zeng L, Hodge R, Atasoy A, Rukazenkov Y, Herbst RS; ADAURA Investigators. Wu YL, et al. N Engl J Med. 2020 Oct 29;383(18):1711-1723. doi: 10.1056/NEJMoa2027071. Epub 2020 Sep 19. N Engl J Med. 2020. PMID: 32955177 Clinical Trial.
Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trial.
Petracci E, Scarpi E, Passardi A, Biggeri A, Milandri C, Vecchia S, Gelsomino F, Tassinari D, Tamberi S, Bernardini I, Accettura C, Frassineti GL, Amadori D, Nanni O. Petracci E, et al. Among authors: tassinari d. Ther Adv Med Oncol. 2020 Jul 23;12:1758835920937427. doi: 10.1177/1758835920937427. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32754229 Free PMC article.
191 results